Pablo Lapuerta
Found 2 people in New Jersey
-
+98
-
+97
-
+96
-
-
+94
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
pablo lapuerta - @PLapuerta
Pablo Lapuerta - @PabloLapuerta
Máster en enterarse de las cosas el último.
Sponsored by SpokeoPaid Service
Sponsored by SpokeoPaid Service
Pablo Lapuerta
Sponsored by PeopleLookerPaid Service
Search for contact info, city & state history, relatives, jobs, education & more
Search public records
Pablo lapuerta traba - @pablolapu
16 followers
Pablo Canet Lapuerta - @pabloperritos
2 followers
pablodelapuerta - @pablodelapuerta
13 followers
PabloLaputa - @pablolaputa
Official Tiktok PabloLaputa . Jangan lupa di follow guys, semoga menghibur !!!
50k followers
Pablo Laguerta - @pablolaguerta
76 followers
Pablo Lapuerta - @calabazero
10 subscribers
Pablo Lapuerta Villanueva
Project manager industry - Grupo Sesé
Robert Acevedo
Pharmaceutical Compounder - Bausch + Lomb
New Hampshire Pharmacists Association
Professional Organization
Experience: NEW HAMPSHIRE PHARMACISTS ASSOCIATION
Jeffrey Freitag, MD
PharmaNet Development Group
Teri Sulser
Pharmaceutical Specialist - Novartis
Education: University of Wisconsin-Whitewater
Julie Gerberding
Foundation for the National Institutes of Health
Fouad Namouni
Robert Wasserman
Tom Redford, PharmD
Sole Proprietor
Bhavik Sojitra
S&P Consulting, LLC
Jessica (Ihne) Reed, PhD
Merck
Education: Georgetown University
Pablo Lapuerta
Sponsored by PeopleLookerPaid Service
Search for Pablo Lapuerta's city and state history
Search address history4M Therapeutics Reports Positive Results from 4MT2001 GLP Safety Studies
Business Wire - Wed, 11 Jun 2025
Changes in Weight Associated With Telotristat Ethyl in the Treatment of Carcinoid Syndrome
ScienceDirect.com - Wed, 02 May 2018
Diabetes Pill Given a Coin Flip’s Chance of Approval Ahead of FDA Meeting
Bloomberg.com - Wed, 16 Jan 2019
4M Therapeutics’ Compounds to Be Utilized in Research Project Funded by National Institute on Aging
FinancialContent - Thu, 17 Oct 2024
4M Therapeutics Announces Positive Preclinical Data for Lead Asset 4MT2001 Demonstrating Central Nervous System Target Engagement
Business Wire - Mon, 09 Sep 2024
Startup World Cup: Harvard Alumni Founders To Compete For $1M Prize
News Mobile - Fri, 12 Sep 2025
-
-
Pablo Lapuerta - @pablolapmur
0 followers
Pablo Lapuerta - @pablolapuerta
2 followers
Pablo Lapuerta - BIO Investor Forum 2024
Pablo Lapuerta has 25 years of experience in the biotech industry and a track record of successful drug approvals including Xermelo, Inpefa, Abilify, and ...
General 2 — 4M Therapeutics
Pablo Lapuerta, MD ... Dr. Lapuerta has 25 years of experience in the biotech industry and a track record of successful drug approvals including Xermelo, Inpefa, ...
Pablo Lapuerta - Chief Executive Officer @ 4M Therapeutics Inc.
Pablo Lapuerta is the Chief Executive Officer at 4M Therapeutics Inc. He was a former Executive Vice President of Clinical Development and Chief Medical ...
Lapuerta Consulting
Pablo Lapuerta, MD is a consultant in the biotech industry helping clients advance their drug development programs. Contact him for more information.
Pablo LAPUERTA | Lexicon Pharmaceuticals, The Woodlands
Pablo LAPUERTA, Executive Vice President and Chief Medical Officer | Cited by 8235 | of Lexicon Pharmaceuticals, The Woodlands | Read 173 publications ...
Dr. Pablo Lapuerta, MD – Skillman, NJ | Internal Medicine - Doximity
Pablo Lapuerta MD. Internal Medicine• Skillman, NJ. Chief Medical Officer, Lexicon Pharmaceuticals.
Pablo Lapuerta - Innovation in Psychosis Therapeutics Summit
June 9-11, 2025 | Boston, MA · Register by Friday, May 16 & Save $300 · Pablo Lapuerta · VENUE · LOCATION · OUR CONTACT DETAILS · JOIN OUR TEAM · ABOUT US.
Pablo Lapuerta - Media Centre - Easd.org
Pablo Lapuerta. Skillman, USA. BIOGRAPHY. Dr. Lapuerta has 26 years of experience in the biotech industry. Currently he is a consultant for biotech clients and ...
Pablo Lapuerta (0000-0003-0704-0251) - ORCID
Pablo Lapuerta · 0000-0003-0704-0251 · Personal information · Activities · ORCID Cookie Consent · ORCID Cookie Settings.
The Exciting Future of Medicine with Pablo Lapuerta
Pablo Lapuerta is the Executive Vice President and Chief Medical Officer of Lexicon Pharmaceuticals. Prior to joining Lexicon in 2011, ...
Pablo Lapuerta, MD - Journal of Oncology Navigation & Survivorship
Pablo Lapuerta, MD. Authored Items. Carcinoid Syndrome Impact Survey: Evaluation of the Burden of Illness and the Gap Between Patient and Oncologist ...
Pablo Lapuerta - RAND
Pablo Lapuerta · Quality of Care for Hypertension in the United States. 2005 · A New Approach for Measuring Quality of Care for Women with Hypertension. 2001.
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief ...
Lexicon Pharmaceuticals Appoints Dr. Pablo Lapuerta Chief Medical Officer. News provided by. Lexicon Pharmaceuticals, Inc. Mar 24, 2011 ...
Pablo Lapuerta - Media Centre | EASD
Pablo Lapuerta. Show Co-Authors. Sotagliflozin reduces glucose variability and risk for hyperglycaemia in adults with type 1 diabetes. ePoster # 717.
Dr. Pablo Lapuerta Archives - Carcinoid Cancer Foundation
Tag: Dr. Pablo Lapuerta · Lexicon's Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial · Lexicon Pharmaceuticals Begins Phase 3 ...
Pablo Lapuerta - Google Scholar
Pablo Lapuerta. President, Lapuerta Consulting. Verified email at lapuertaconsulting.com - Homepage · Biotechnology. ArticlesCited byPublic access ...
Pablo Lapuerta - OpenAlex
Alternate names Pablo Lapuerta, P. Lapuerta ; Institution Lexicon Pharmaceuticals (United States) ; ORCID: Yes ; H-index: 43 ; I10-index: 82 ...
Pablo Lapuerta - Home
Pablo Lapuerta · Most frequent co-Author · Most cited colleague · Most frequent Affiliation.
Pablo Lapuerta, MD - Academy of Oncology Nurse & Patient ...
Pablo Lapuerta, MD. Authored Items. Last modified: March 27, 2024. Thank You to Our Corporate Sponsors and Alliance Partners! AstraZeneca. Major Corporate ...
Pablo LAPUERTA personal appointments - Companies House
Pablo LAPUERTA · Filter appointments · Total number of appointments 1 · COGENTUS PHARMACEUTICALS INTERNATIONAL LIMITED (06433203) · Support links.
Pablo Lapuerta Email | Chief Executive Officer at 4M Therapeutics Inc.
Pablo Lapuerta. Chief Executive Officer at 4M Therapeutics Inc. | Princeton, New Jersey, United States. View Pablo Lapuerta's Email & Phone Number.
Pablo Lapuerta, Lexicon Pharmaceuticals Inc: Profile and Biography
Pablo Lapuerta is Former Exec VP/Chief Medical Officer at Lexicon Pharmaceuticals Inc. See Pablo Lapuerta's compensation, career history, education, ...
Dr. Pablo Lapuerta, MD - Internist in Skillman, NJ | Healthgrades
Pablo Lapuerta, MD is an internist in Skillman, NJ and has over 35 years of experience in the medical field. He graduated from HARVARD Medical School in 1989.
4M Therapeutics to Present at the Upcoming American ...
... Pablo Lapuerta, M.D., will participate in panel discussions at the upcoming American Psychological Association (APA)'s Annual Meeting taking ...
Pablo Lapuerta - Author Profile - zbMATH Open
Lapuerta, Pablo · Co-Authors · Serials · Fields · Publications by Year · Citations contained in zbMATH Open · Cited by 23 Authors · Cited in 6 Serials · Cited in 3 ...
Neural Networks, Logistic Regression, and Calibration: A Reply ...
Neural Networks, Logistic Regression, and Calibration: A Reply. Pablo Lapuerta, MD, Gilbert L'Italien, PhD, […], Robert Giugliano, MD, SM, and Kim A. Eagle ...